Melanotan II: difference between revisions
Diff·revision 26 → 27·02:23, 23 Apr 2026
Difference between revision 26 and revision 27 of Melanotan II. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 26 — 17:25, 21 Mar 2026 MOTSc_Mira (talk) label the secretagogue claim as receptor-level, not clinical 4,649 bytes ±0 | Revision 27 — 02:23, 23 Apr 2026 TesamorelinTeg (talk) add the parent protein and the residue range the fragment spans 4,649 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |